Months after divesting seven European sites, the Swedish contract development and manufacturing organisation (CDMO) Recipharm ...

Artificial intelligence (AI) is now infiltrating core industries and according to Forbes, the market is expected to reach a ...

The partners are preparing for commercialization of the lung cancer drug limertinib as they await an approval decision from China’s National Drug Administration.

In today's regulatory landscape, ensuring data integrity is crucial for compliance and process visibility. How can ...

The proceeds of the financing will support the development of LoQus23’s lead candidate, a small molecule inhibitor that is ...

SK Group’s contract development and manufacturing organization (CDMO) arm SK pharmteco is spending $260 million to expand its ...

As CPHI Milan 2024 approaches, Symbiosis Pharmaceutical Services is gearing up to showcase major expansions and innovations ...

Outsourcing Pharma sat down ahead of CPHI with Dr Andreas Raabe, CEO of Adragos Pharma, to explore the evolving world of ...

Rebekah's father passed on his passion for science and problem solving to her and much her of childhood was spent doing fun ...

Patient recruitment is a critical and often challenging aspect of clinical trials, particularly for biopharmaceutical ...

The company will introduce its innovative siliconized moulded glass vials, positioning itself as the only global supplier ...

At this October’s CPHI event being held in Milan, dsm-firmenich, is inviting stakeholders across the pharmaceutical market to ...